99 related articles for article (PubMed ID: 12742275)
1. Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification.
Alsbeih G; Story MD; Maor MH; Geara FB; Brock WA
Radiother Oncol; 2003 Mar; 66(3):341-4. PubMed ID: 12742275
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome.
Bakhshi S; Cerosaletti KM; Concannon P; Bawle EV; Fontanesi J; Gatti RA; Bhambhani K
J Pediatr Hematol Oncol; 2003 Mar; 25(3):248-51. PubMed ID: 12621246
[TBL] [Abstract][Full Text] [Related]
3. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
4. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of radiation for medulloblastoma on intellectual and physical development. A case report of monozygotic twins.
Nishiyama K; Funakoshi S; Izumoto S; Ikeda T; Oku Y
Cancer; 1994 May; 73(9):2450-5. PubMed ID: 8168048
[TBL] [Abstract][Full Text] [Related]
6. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia.
Hart RM; Kimler BF; Evans RG; Park CH
Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1237-40. PubMed ID: 3610711
[TBL] [Abstract][Full Text] [Related]
8. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapeutic management of medulloblastoma.
Paulino AC
Oncology (Williston Park); 1997 Jun; 11(6):813-23; discussion 823, 827-8, 831. PubMed ID: 9189939
[TBL] [Abstract][Full Text] [Related]
10. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
11. MDM2 overexpression is associated with short survival in adults with medulloblastoma.
Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A
Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):106-12. PubMed ID: 19695790
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity.
Huang E; Teh BS; Strother DR; Davis QG; Chiu JK; Lu HH; Carpenter LS; Mai WY; Chintagumpala MM; South M; Grant WH; Butler EB; Woo SY
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):599-605. PubMed ID: 11849779
[TBL] [Abstract][Full Text] [Related]
14. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
[TBL] [Abstract][Full Text] [Related]
15. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.
Brodin NP; Munck Af Rosenschöld P; Aznar MC; Kiil-Berthelsen A; Vogelius IR; Nilsson P; Lannering B; Björk-Eriksson T
Acta Oncol; 2011 Aug; 50(6):806-16. PubMed ID: 21767178
[TBL] [Abstract][Full Text] [Related]
16. Recent progress and results of modern radiation therapy in medulloblastoma.
Chin HW; Maruyama Y
Prog Clin Biol Res; 1983; 130():401-10. PubMed ID: 6413977
[No Abstract] [Full Text] [Related]
17. Radiation for medulloblastoma adjusted to prevent recurrence to the cribriform plate region.
Jereb B; Krishnaswami S; Reid A; Allen JC
Cancer; 1984 Aug; 54(3):602-4. PubMed ID: 6733691
[TBL] [Abstract][Full Text] [Related]
18. Results of radiation treatment of cerebellar medulloblastoma.
Chin HW; Maruyama Y
Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):737-42. PubMed ID: 7287534
[No Abstract] [Full Text] [Related]
19. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
20. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
